These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 32409380)
41. Duration of vitamin K-antagonist treatment before DC cardioversion does not affect recurrence rate in patients with atrial fibrillation. Nybo M; Sørensen CE; Budtz AE; Henriksen FL; Brandes A Int J Cardiol; 2013 Oct; 168(3):2986-8. PubMed ID: 23639467 [No Abstract] [Full Text] [Related]
42. Cardioversion of persistent atrial fibrillation--not yet an outdated treatment. Gjesdal K Scand Cardiovasc J; 2003 Dec; 37(6):307-8. PubMed ID: 14668178 [No Abstract] [Full Text] [Related]
43. Positive atrial inotropic effect of dofetilide after cardioversion of atrial fibrillation or flutter. DeCara JM; Pollak A; Dubrey S; Falk RH Am J Cardiol; 2000 Sep; 86(6):685-8, A8. PubMed ID: 10980226 [TBL] [Abstract][Full Text] [Related]
44. [Electrical and pharmacological strategies for early cardioversion of atrial fibrillation]. Linhart M; Lewalter T Herzschrittmacherther Elektrophysiol; 2006 Jun; 17(2):81-8. PubMed ID: 16786466 [TBL] [Abstract][Full Text] [Related]
46. Ventricular pauses during atrial fibrillation predict relapse after electrical cardioversion: a prospective study. Gallagher MM; Guo XH; Poloniecki J; Camm AJ Pacing Clin Electrophysiol; 2010 Aug; 33(8):934-8. PubMed ID: 20487347 [TBL] [Abstract][Full Text] [Related]
47. Early experience of nurse-led elective DC cardioversion. Quinn T Nurs Crit Care; 1998; 3(2):59-62. PubMed ID: 9883163 [TBL] [Abstract][Full Text] [Related]
48. Direct current cardioversion of established atrial fibrillation. Lévy S Clin Cardiol; 1992 Jun; 15(6):445-9. PubMed ID: 1617825 [TBL] [Abstract][Full Text] [Related]
49. [Cardioversion in atrial fibrillation. Results and complications in 1,152 prospective patients. Study Group of the Working Society of Leading Cardiologic Hospital Physicians]. Tebbe U; Carlsson J; Seidl K; Jansen W; Schuster HP; Elsner M; Neuhaus KL; Praetorius F Med Klin (Munich); 1995 Dec; 90(12):681-7. PubMed ID: 8583983 [TBL] [Abstract][Full Text] [Related]
50. Reduced high serum hepatocyte growth factor levels after successful cardioversion in patients with atrial fibrillation. Katoh H; Shimada T; Inoue S; Takahashi N; Shimizu H; Ohta Y; Nakamura K; Murakami Y; Ishibashi Y; Matsumori A Clin Exp Pharmacol Physiol; 2004 Mar; 31(3):145-51. PubMed ID: 15008956 [TBL] [Abstract][Full Text] [Related]
56. Impact of Pre-Ablation Direct Current Cardioversion for Persistent Atrial Fibrillation to Predict Recurrence of Atrial Fibrillation after Catheter Ablation. Kamada H; Mori K; Ueda N; Wakamiya A; Nakajima K; Kamakura T; Wada M; Ishibashi K; Yamagata K; Inoue Y; Miyamoto K; Nagase S; Noda T; Izumi C; Noguchi T; Kusano K; Aiba T Int Heart J; 2022; 63(5):828-836. PubMed ID: 36184544 [TBL] [Abstract][Full Text] [Related]
57. Cardioversion of pre-excited atrial fibrillation leading to ventricular fibrillation- case report and review of literature. Danon A; Militianu A; Schliamser JE Am J Emerg Med; 2019 Aug; 37(8):1539-1543. PubMed ID: 31126668 [TBL] [Abstract][Full Text] [Related]
58. Factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation. Frick M; Frykman V; Jensen-Urstad M; Ostergren J; Rosenqvist M Clin Cardiol; 2001 Mar; 24(3):238-44. PubMed ID: 11288971 [TBL] [Abstract][Full Text] [Related]
59. Systolic time intervals before and after cardioversion of atrial fibrillation. van Herick R; Orlando J; Aronow WS Chest; 1979 Mar; 75(3):359-61. PubMed ID: 421579 [TBL] [Abstract][Full Text] [Related]
60. Electrical cardioversion of atrial fibrillation: different methods for a safe and effective technique. Santini L; Forleo GB; Topa A; Romeo F; Santini M Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):601-10. PubMed ID: 16076271 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]